{"name":"Biostar Pharma, Inc.","slug":"biostar-pharma-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","status":"active","statusNote":"","leadDrug":"","leadIndication":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":2384492,"revenueGrowth":-91.2,"grossMargin":38.4,"rdSpend":1144044,"netIncome":-5698385,"cash":173290,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2016"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"Utidelone in combination with capecitabine","genericName":"Utidelone in combination with capecitabine","slug":"utidelone-in-combination-with-capecitabine","indication":"Other","status":"phase_2"}]}],"pipeline":[{"name":"Utidelone in combination with capecitabine","genericName":"Utidelone in combination with capecitabine","slug":"utidelone-in-combination-with-capecitabine","phase":"phase_2","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMi4wFBVV95cUxPcks5YlRxc2Z6cjVPd2w0aXIxdVFGY0wzcW9wXzNObTlyRy1RSXNQMlRHRkRISVVJUThURGkzREVNV1Z6bnBmaHk2LUFEeFd0djFVZDEwWlZFbl82ZkRNQ215OVRFMVEwZEQ4V0NYaWJaUFB0S0FRS05Ta0ZmNk44cGdwbU1WVFR3akpxUXh0SndyX2hRekN6Rk9MOE1Da2Fxb0h3ZTdrQTFGV3FLLTVySTNILUgtYjFtTnRoeVNnai1wbUFpTWdvcmZHd3NQUWJnZV8tbUtwVVVGel93OE1KZk5Xcw?oc=5","date":"2026-03-30","type":"earnings","source":"marketscreener.com","summary":"Beijing Biostar Pharmaceuticals Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2025 - marketscreener.com","headline":"Beijing Biostar Pharmaceuticals Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2025","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMibEFVX3lxTE5NZkZlc3l0VTRHTkZIcEE1NGlUTDhHY2lnbGVtMzNSSGY2YVdpUnRYaFVPWnNGaE9BR1dsZkVCTS1Bb2lub3oyM1BIckNuRE0xbEZRLWNlSEpiamo2QXN0VEUtUGxkMWlBeDdmZw?oc=5","date":"2026-03-30","type":"pipeline","source":"Yahoo Finance Singapore","summary":"CANbridge Pharmaceuticals Inc. (1228.HK) Analyst insights, Price targets and Recommendations - Yahoo Finance Singapore","headline":"CANbridge Pharmaceuticals Inc. (1228.HK) Analyst insights, Price targets and Recommendations","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimAFBVV95cUxPUU9GX21ndGt0WW1pWjVVOUZld0gtM09LcC1BLURCMjgxckI0VGV4MXduQTJ4eDNGTkN1SU8wcnBkTlFfeW5rMFlJU1FabUVTVFE1eC12czZZMzhKQzdvVU1ORmZSTjhaV3NzaHU3Rjl3WS1taXQ4dHJCV1NMb2dBVmphRldfcUpWOFRxZG9pOElaS1RmR1VtTw?oc=5","date":"2026-03-20","type":"trial","source":"openPR.com","summary":"Breast Cancer Clinical Trial Gains Momentum: 250+ Companies - openPR.com","headline":"Breast Cancer Clinical Trial Gains Momentum: 250+ Companies","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijgFBVV95cUxOZUZjdThLNXR5VVpDMDZPMUN3S1VKclQxekZLa1YyQlpMVEhJSkZRdDllb05ydF9OcF9uV2JmZUdGdEMya1VoTWViTTBXMVZJT1RqQkFOaXNKZXlSWjI1YWpVS1RWdk9ZRVBXQUZaNnEwWW1Dbm8tVFk1MjlnYzhfM2JLS2kzRUNRcXl4UHZB?oc=5","date":"2026-03-16","type":"pipeline","source":"The Guardian","summary":"Chinese-owned Syngenta to build new £100m bioscience hub in UK - The Guardian","headline":"Chinese-owned Syngenta to build new £100m bioscience hub in UK","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilgFBVV95cUxQUDRET3QyNXZaeWY3TXhIZHpnWjBoLVhqQVVxT21NaWxRWmljWHlPNGt0VHN3N0V6enY5bGI4b1U2WTE4OHoxd3lUZ1BEMWh6T1c2amxtbDc2V3FfZ0tPYy0xa3RTXy1zQmt3Wi1kQUMyRmVWMjl2TjdyUzhfeEI0NjQxc183MDlXS1VpSXJ2aTV6YklpQUE?oc=5","date":"2025-11-05","type":"pipeline","source":"aviNews","summary":"BioStar champions natural health solutions for Philippine livestock - aviNews","headline":"BioStar champions natural health solutions for Philippine livestock","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMinwFBVV95cUxQU3FjcFJyeFF3cXBwZHhlM2l5SXo2ZkJUbENxSk00bE5sU1FCRC12WVBXR2dBZEtMeWJBdlgxeWJBLVB0cXYxWTI0NUZfMDF1cnYzT01scUxpSE9obzdOVkNJSUF4Qm9LTlowcTgtc055eXNBaXl5TUM1RW9QN1NtRlhGWGlseWtkcko1REJJYlpsVzNvYlhiSm41WkV6LUU?oc=5","date":"2024-04-03","type":"regulatory","source":"CancerNetwork","summary":"Novel Injection Earns FDA ODD in Breast Cancer Brain Metastases - CancerNetwork","headline":"Novel Injection Earns FDA ODD in Breast Cancer Brain Metastases","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipwFBVV95cUxPRzB0anRmaFhtOVlCUjdGUVc1YkxCTEFpM3ZsZzNibnpGbWVfUFo0ZlhxbDVwZmlEbk1XSGthc0I0MUJpMjlLZm5faVBWdFNuVGJwMHF1TTJpRHU4WnZhZE9FU25mRkFoMk15V1ZmQzBQcURIdTFqTGlnSkFDaTdzTDhNTEY3UWxlTWdfM1FQVXhKTUh6WmJIdmtaMHQ1SzYzb3daWUgxbw?oc=5","date":"2024-04-01","type":"regulatory","source":"OncLive","summary":"UTD1 Receives FDA Orphan Drug Designation in Breast Cancer Brain Metastasis - OncLive","headline":"UTD1 Receives FDA Orphan Drug Designation in Breast Cancer Brain Metastasis","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipgFBVV95cUxPTndZVlNlcWdkUU1JVlJHR1FfbEpScW1XaVFJOVMyMTNMdFY5d1hZNjVQZnJ1Wi14YUYySEo4VDdNOVVjdXdWSHMzRW1TYTJZRHZ5b25YWWtsUGI3anh0azJpOFpycUpLQWlweW04TEp1bXlNMF9STUJjbFBIaXRNZ2U4cG9nam1qWWpqTWdqdFRCOEdKQ0NvTDFfOXcyUFVIYTE3YW5B?oc=5","date":"2024-03-25","type":"regulatory","source":"Pharmacy Times","summary":"FDA Grants ODD to Utidelone Capsules For Treatment of Gastric Cancer - Pharmacy Times","headline":"FDA Grants ODD to Utidelone Capsules For Treatment of Gastric Cancer","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiSEFVX3lxTFBXeE4yV29HMElpcVRsbnNBSjZTV1ZVSWRkZlBoZDgxLUtiNjdMR3VkYjliejhvZkt4R3dtYWQ3Ulhwczk1eEpYbA?oc=5","date":"2020-12-06","type":"deal","source":"StockInvest.us","summary":"Biostar Pharmaceuticals Stock Price Forecast. Should You Buy BSPM? - StockInvest.us","headline":"Biostar Pharmaceuticals Stock Price Forecast. Should You Buy BSPM?","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitAFBVV95cUxQWkEtTnprOGoxbVpUMlNvQVVobGFRMTZ5Zk1ia1U5aWl1UWFpbml1bFBWZ3FQeFRPc2RoY0ZnTVVpSXBRVnpSdXpyTzhYT1VZWUhoVDhENUJSMG40dzA0bkdiOUR5NXpua3lORlJtZlFBamctZ25hS2UyNG5vZFFzcW9zcU5oaElrQXM4TXNQYXNTbkJvMkEySlVOUHBCVkNGTVpYaTdiU3B4d0FNaTBsTDZnSTg?oc=5","date":"2019-07-11","type":"pipeline","source":"Fortune Business Insights","summary":"Contract Research Organization [CRO] Services Market, 2034 - Fortune Business Insights","headline":"Contract Research Organization [CRO] Services Market, 2034","sentiment":"neutral"},{"date":"2018-08-24","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: FORM 8-K","headline":"SEC 8-K: FORM 8-K","sentiment":"neutral"},{"date":"2018-07-25","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: 8-K","headline":"SEC 8-K: 8-K","sentiment":"neutral"},{"date":"2018-07-06","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: 8-K","headline":"SEC 8-K: 8-K","sentiment":"neutral"},{"date":"2018-07-02","type":"earnings","source":"SEC EDGAR","summary":"SC 13D filed with SEC: SC 13D","headline":"SC 13D Filing","sentiment":"neutral"},{"date":"2018-05-30","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: 8-K","headline":"SEC 8-K: 8-K","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_2":1},"enrichmentLevel":3,"visitCount":3,"keyCompetitors":[],"therapeuticFocus":[],"financials":{"source":"sec_edgar+yahoo","revenue":2384492,"revenuePeriod":"2016-12-31","revenueHistory":[{"value":2384492,"period":"2016-12-31"},{"value":27129609,"period":"2015-12-31"},{"value":61416587,"period":"2014-12-31"},{"value":52729054,"period":"2013-12-31"},{"value":49317844,"period":"2012-12-31"},{"value":91965505,"period":"2011-12-31"}],"grossProfit":915174,"grossProfitHistory":[],"rdSpend":1144044,"rdSpendHistory":[],"sgaSpend":null,"operatingIncome":null,"operatingIncomeHistory":[],"netIncome":-5698385,"netIncomeHistory":[],"eps":null,"epsHistory":[],"cash":173290,"cashHistory":[],"totalAssets":42502438,"totalLiabilities":null,"totalDebt":null,"equity":null,"operatingCashflow":null,"operatingCashflowHistory":[],"capex":null,"capexHistory":[],"freeCashflow":null,"dividendsPaid":null,"buybacks":null,"employees":null,"segmentRevenue":[],"geographicRevenue":[],"quarterly":{"income":[]},"ciks":null,"lastFiledAt":null},"yahoo":null}